Botswana

Botswana

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
4.12 (3.33 - 5) 2019 Modelled IHME
4.43 (3.60 - 5.30) 2018 Modelled IHME
4.57 (3.71 - 5.48) 2017 Modelled IHME
4.57 (3.77 - 5.41) 2016 Modelled IHME
4.58 (3.75 - 5.45) 2015 Modelled IHME
4.62 (3.81 - 5.45) 2014 Modelled IHME
4.71 (3.89 - 5.57) 2013 Modelled IHME
4.83 (3.94 - 5.79) 2012 Modelled IHME
4.97 (4.02 - 5.97) 2011 Modelled IHME
5.1 (4.10 - 6.16) 2010 Modelled IHME
5.24 (4.23 - 6.34) 2009 Modelled IHME
5.39 (4.36 - 6.61) 2008 Modelled IHME
5.55 (4.50 - 6.83) 2007 Modelled IHME
5.72 (4.63 - 7.06) 2006 Modelled IHME
5.89 (4.72 - 7.29) 2005 Modelled IHME
6.07 (4.90 - 7.58) 2004 Modelled IHME
6.27 (5.06 - 7.76) 2003 Modelled IHME
6.47 (5.17 - 7.96) 2002 Modelled IHME
6.66 (5.26 - 8.17) 2001 Modelled IHME
6.84 (5.38 - 8.44) 2000 Modelled IHME
7.01 (5.51 - 8.55) 1999 Modelled IHME
7.16 (5.72 - 8.73) 1998 Modelled IHME
7.31 (5.88 - 8.88) 1997 Modelled IHME
7.46 (6.03 - 9.06) 1996 Modelled IHME
7.63 (6.18 - 9.28) 1995 Modelled IHME
7.81 (6.35 - 9.49) 1994 Modelled IHME
8.01 (6.47 - 9.76) 1993 Modelled IHME
8.21 (6.58 - 10.04) 1992 Modelled IHME
8.43 (6.68 - 10.25) 1991 Modelled IHME
8.66 (6.79 - 10.60) 1990 Modelled IHME
1.34 (0.15 - 13.37) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
1.39 (0.98 - 1.84) 2019 Modelled IHME
1.47 (1.07 - 2) 2018 Modelled IHME
1.48 (1.08 - 2.06) 2017 Modelled IHME
1.36 (1 - 1.81) 2016 Modelled IHME
1.19 (0.86 - 1.55) 2015 Modelled IHME
1.11 (0.81 - 1.45) 2014 Modelled IHME
1.04 (0.76 - 1.37) 2013 Modelled IHME
0.99 (0.73 - 1.31) 2012 Modelled IHME
0.95 (0.70 - 1.27) 2011 Modelled IHME
0.92 (0.68 - 1.25) 2010 Modelled IHME
0.91 (0.67 - 1.22) 2009 Modelled IHME
0.9 (0.66 - 1.19) 2008 Modelled IHME
0.9 (0.66 - 1.17) 2007 Modelled IHME
0.89 (0.65 - 1.17) 2006 Modelled IHME
0.89 (0.65 - 1.18) 2005 Modelled IHME
1.04 (0.77 - 1.38) 2004 Modelled IHME
1.42 (1.04 - 1.89) 2003 Modelled IHME
1.86 (1.36 - 2.50) 2002 Modelled IHME
2.23 (1.62 - 3.01) 2001 Modelled IHME
2.38 (1.71 - 3.23) 2000 Modelled IHME
2.31 (1.68 - 3.14) 1999 Modelled IHME
2.15 (1.57 - 2.89) 1998 Modelled IHME
1.95 (1.44 - 2.61) 1997 Modelled IHME
1.79 (1.31 - 2.38) 1996 Modelled IHME
1.72 (1.27 - 2.29) 1995 Modelled IHME
1.99 (1.47 - 2.61) 1994 Modelled IHME
2.73 (1.99 - 3.58) 1993 Modelled IHME
3.84 (2.79 - 5.02) 1992 Modelled IHME
5.21 (3.78 - 6.84) 1991 Modelled IHME
6.75 (4.85 - 8.95) 1990 Modelled IHME
0.19 (0.02 - 2.01) 2015 Modelled WHO
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
39 (31 - 49) 2019 Modelled IHME
40 (32 - 49) 2018 Modelled IHME
40 (32 - 49) 2017 Modelled IHME
40 (32 - 49) 2016 Modelled IHME
40 (32 - 49) 2015 Modelled IHME
40 (32 - 49) 2014 Modelled IHME
40 (32 - 49) 2013 Modelled IHME
40 (33 - 49) 2012 Modelled IHME
40 (33 - 50) 2011 Modelled IHME
41 (33 - 50) 2010 Modelled IHME
40 (32 - 49) 2009 Modelled IHME
40 (32 - 49) 2008 Modelled IHME
40 (32 - 50) 2007 Modelled IHME
40 (32 - 50) 2006 Modelled IHME
40 (32 - 50) 2005 Modelled IHME
40 (32 - 50) 2004 Modelled IHME
41 (32 - 51) 2003 Modelled IHME
42 (33 - 52) 2002 Modelled IHME
42 (33 - 53) 2001 Modelled IHME
43 (34 - 53) 2000 Modelled IHME
43 (34 - 53) 1999 Modelled IHME
43 (34 - 52) 1998 Modelled IHME
42 (34 - 52) 1997 Modelled IHME
42 (34 - 51) 1996 Modelled IHME
41 (33 - 50) 1995 Modelled IHME
40 (32 - 50) 1994 Modelled IHME
39 (31 - 49) 1993 Modelled IHME
38 (30 - 49) 1992 Modelled IHME
38 (29 - 49) 1991 Modelled IHME
37 (28 - 49) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
95 2018 Survey/reported WHO/UNICEF
95 2017 Survey/reported WHO/UNICEF
95 2016 Survey/reported WHO/UNICEF
95 2015 Survey/reported WHO/UNICEF
95 2014 Survey/reported WHO/UNICEF
95 2013 Survey/reported WHO/UNICEF
95 2012 Survey/reported WHO/UNICEF
95 2011 Survey/reported WHO/UNICEF
95 2010 Survey/reported WHO/UNICEF
94 2009 Survey/reported WHO/UNICEF
94 2008 Survey/reported WHO/UNICEF
93 2007 Survey/reported WHO/UNICEF
93 2006 Survey/reported WHO/UNICEF
92 2005 Survey/reported WHO/UNICEF
91 2004 Survey/reported WHO/UNICEF
90 2003 Survey/reported WHO/UNICEF
88 2002 Survey/reported WHO/UNICEF
87 2001 Survey/reported WHO/UNICEF
86 2000 Survey/reported WHO/UNICEF
85 1999 Survey/reported WHO/UNICEF
77 1998 Survey/reported WHO/UNICEF
60 1997 Survey/reported WHO/UNICEF
62 1996 Survey/reported WHO/UNICEF
73 1995 Survey/reported WHO/UNICEF
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
1998
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.6 (1.28 - 2) 2019 Modelled IHME
1.59 (1.28 - 2) 2018 Modelled IHME
1.59 (1.29 - 1.98) 2017 Modelled IHME
1.56 (1.27 - 1.95) 2016 Modelled IHME
1.54 (1.23 - 1.92) 2015 Modelled IHME
1.54 (1.24 - 1.92) 2014 Modelled IHME
1.54 (1.24 - 1.92) 2013 Modelled IHME
1.54 (1.25 - 1.92) 2012 Modelled IHME
1.54 (1.25 - 1.92) 2011 Modelled IHME
1.54 (1.24 - 1.93) 2010 Modelled IHME
1.54 (1.24 - 1.93) 2009 Modelled IHME
1.53 (1.24 - 1.92) 2008 Modelled IHME
1.53 (1.24 - 1.92) 2007 Modelled IHME
1.53 (1.23 - 1.91) 2006 Modelled IHME
1.52 (1.22 - 1.90) 2005 Modelled IHME
1.52 (1.22 - 1.90) 2004 Modelled IHME
1.52 (1.22 - 1.90) 2003 Modelled IHME
1.51 (1.21 - 1.90) 2002 Modelled IHME
1.51 (1.21 - 1.90) 2001 Modelled IHME
1.51 (1.21 - 1.90) 2000 Modelled IHME
1.51 (1.21 - 1.90) 1999 Modelled IHME
1.51 (1.21 - 1.91) 1998 Modelled IHME
1.52 (1.21 - 1.91) 1997 Modelled IHME
1.52 (1.22 - 1.92) 1996 Modelled IHME
1.52 (1.22 - 1.92) 1995 Modelled IHME
1.53 (1.22 - 1.93) 1994 Modelled IHME
1.53 (1.22 - 1.93) 1993 Modelled IHME
1.53 (1.22 - 1.93) 1992 Modelled IHME
1.53 (1.22 - 1.93) 1991 Modelled IHME
1.53 (1.22 - 1.93) 1990 Modelled IHME
Showing out of
Show more

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
25 (18 - 32) 2019 Modelled IHME
24 (17 - 31) 2018 Modelled IHME
24 (17 - 31) 2017 Modelled IHME
24 (17 - 32) 2016 Modelled IHME
24 (18 - 32) 2015 Modelled IHME
24 (18 - 31) 2014 Modelled IHME
24 (17 - 31) 2013 Modelled IHME
24 (17 - 31) 2012 Modelled IHME
24 (17 - 31) 2011 Modelled IHME
24 (17 - 30) 2010 Modelled IHME
24 (17 - 31) 2009 Modelled IHME
24 (17 - 31) 2008 Modelled IHME
24 (17 - 31) 2007 Modelled IHME
24 (17 - 31) 2006 Modelled IHME
24 (17 - 31) 2005 Modelled IHME
24 (17 - 31) 2004 Modelled IHME
24 (16 - 31) 2003 Modelled IHME
23 (16 - 31) 2002 Modelled IHME
23 (16 - 31) 2001 Modelled IHME
23 (15 - 30) 2000 Modelled IHME
23 (15 - 30) 1999 Modelled IHME
23 (16 - 31) 1998 Modelled IHME
23 (16 - 31) 1997 Modelled IHME
24 (17 - 32) 1996 Modelled IHME
25 (18 - 33) 1995 Modelled IHME
26 (18 - 35) 1994 Modelled IHME
28 (19 - 36) 1993 Modelled IHME
29 (19 - 38) 1992 Modelled IHME
30 (19 - 39) 1991 Modelled IHME
30 (19 - 41) 1990 Modelled IHME
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
1998
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
4.12 (%)
2019
(3.33 - 5(%))
IHME
HCV (RNA/cAg+)
1.6 (%)
2019
(1.28 - 2(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
91
2019
(57 - 138)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
134
2019
(84 - 202)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
1.39 (%)
2019, latest modelled
(0.98 - 1.84(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines